Jennison Associates
RGNX icon

Jennison Associates’s Regenxbio RGNX Stock Holding History

Jennison Associates’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-38,359
Closed -$689K – 626
2023
Q4 		$689K Buy
38,359
+493
+1% +$8.68K ﹤0.01% 536
2023
Q3 		$623K Buy
37,866
+334
+0.9% +$6.05K ﹤0.01% 519
2023
Q2 		$750K Buy
37,532
+2,304
+7% +$44.4K ﹤0.01% 515
2023
Q1 		$666K Sell
35,228
-6,127
-15% -$136K ﹤0.01% 545
2022
Q4 		$938K Sell
41,355
-1,049
-2% -$23.7K ﹤0.01% 494
2022
Q3 		$1.12M Sell
42,404
-3,164
-7% -$93.9K ﹤0.01% 492
2022
Q2 		$1.13M Buy
45,568
+15,577
+52% +$389K ﹤0.01% 505
2022
Q1 		$995K Buy
+29,991
New +$833K ﹤0.01% 562
2017
Q1 		– Sell
-292,268
Closed -$5.42M – 769
2016
Q4 		$5.42M Buy
292,268
+246
+0.1% +$4.7K 0.01% 510
2016
Q3 		$4.09M Sell
292,022
-380
-0.1% -$4.19K ﹤0.01% 515
2016
Q2 		$2.34M Buy
292,402
+14
+0% +$155 ﹤0.01% 533
2016
Q1 		$3.16M Sell
292,388
-45,690
-14% -$585K ﹤0.01% 511
2015
Q4 		$5.56M Sell
338,078
-17,266
-5% -$343K 0.01% 514
2015
Q3 		$7.67M Buy
+355,344
New +$9.07M 0.01% 521

Other funds holding RGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

Jennison Associates's RGNX Position: Q1 2024 in Review

Jennison Associates sold out of Regenxbio (RGNX) in Q1 2024, closing a stake of 38,359 shares — an estimated $689K sold.

Jennison Associates first reported a position in RGNX in Q3 2015 and held it in 14 quarters. The position peaked at $7.67M in Q3 2015. 188 funds tracked by Wall St. Rank hold RGNX as of Q1 2024.

  • Jennison Associates reported no remaining Regenxbio position as of Q1 2024 after selling out during the quarter.
  • Jennison Associates sold 38,359 Regenxbio shares in Q1 2024, an estimated $689K.
  • Jennison Associates first reported a position in Regenxbio in Q3 2015 and held it in 14 quarters.
  • Jennison Associates's Regenxbio position peaked at $7.67M in Q3 2015.
  • 188 funds tracked by Wall St. Rank held Regenxbio as of Q1 2024.

Based on Jennison Associates's 13F filing for Q1 2024, filed 2 May 2024.